Home/Filings/4/0001104659-17-067963
4//SEC Filing

Ravina Bernard 4

Accession 0001104659-17-067963

CIK 0001640266other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:15 PM ET

Size

5.2 KB

Accession

0001104659-17-067963

Insider Transaction Report

Form 4
Period: 2017-11-10
Ravina Bernard
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2017-11-10$13.26/sh5,490$72,79716,473 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.50, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Documents

1 file

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001711276

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:15 PM ET
Size
5.2 KB